We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALTM
901
DELISTED
Arcadium Lithium plc
ALTM
$32.5K ﹤0.01%
+11,415
New +$33K
AA icon
902
Alcoa
AA
$11.6B
– –
-8,803
Closed -$350K
AAON icon
903
Aaon
AAON
$8.27B
– –
-10,669
Closed -$931K
ABM icon
904
ABM Industries
ABM
$2.84B
– –
-18,557
Closed -$938K
ABT icon
905
Abbott
ABT
$182B
– –
-17,178
Closed -$1.78M
ACHC icon
906
Acadia Healthcare
ACHC
$2.99B
– –
-7,123
Closed -$481K
ACLS icon
907
Axcelis
ACLS
$3.94B
– –
-2,383
Closed -$339K
ACMR icon
908
ACM Research
ACMR
$5.53B
– –
-15,255
Closed -$352K
ADBE icon
909
Adobe
ADBE
$94.5B
– –
-782
Closed -$434K
ADM icon
910
Archer Daniels Midland
ADM
$40.1B
– –
-4,851
Closed -$293K
ADPT icon
911
Adaptive Biotechnologies
ADPT
$3.61B
– –
-15,011
Closed -$54.3K
ADT icon
912
ADT
ADT
$5.24B
– –
-72,843
Closed -$554K
AEM icon
913
Agnico Eagle Mines
AEM
$73B
– –
-13,442
Closed -$879K
AEO icon
914
American Eagle Outfitters
AEO
$2.98B
– –
-17,194
Closed -$343K
AEP icon
915
American Electric Power
AEP
$72.7B
– –
-18,232
Closed -$1.6M
AFG icon
916
American Financial Group
AFG
$12B
– –
-14,811
Closed -$1.82M
AGNC icon
917
AGNC Investment
AGNC
$12.4B
– –
-35,851
Closed -$342K
AIT icon
918
Applied Industrial Technologies
AIT
$12.9B
– –
-6,527
Closed -$1.27M
ALGT icon
919
Allegiant Air
ALGT
$2.66B
– –
-11,174
Closed -$561K
ALKS icon
920
Alkermes
ALKS
$8.79B
– –
-8,924
Closed -$215K
AMN icon
921
AMN Healthcare
AMN
$1.3B
– –
-6,516
Closed -$334K
AMRX icon
922
Amneal Pharmaceuticals
AMRX
$5.78B
– –
-119,284
Closed -$757K
ANF icon
923
Abercrombie & Fitch
ANF
$4.41B
– –
-9,871
Closed -$1.76M
APP icon
924
Applovin
APP
$139B
– –
-25,044
Closed -$2.08M
APPF icon
925
AppFolio
APPF
$5.98B
– –
-1,052
Closed -$257K
35 36
37
38 39

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.